Cystic Fibrosis

May 20, 2016May 20, 2016

U. Washington Scientists’ Sensing Tool Measures Lung Function over Calls from any Phone, Anywhere

Most people in the developing world who live with asthma, cystic fibrosis, or other chronic lung diseases have no way of measuring the status of their lung function outside of ... Read more

May 18, 2016May 18, 2016

Potential New Drug Fights Bacteria and Viruses at Same Time, Researchers Say

Cystic Fibrosis, News

A potential new drug may help fight bacterial and viral infections at once, new research shows. With the immune response against viral infections making us susceptible to antibiotic resistant bacterial ... Read more

May 17, 2016May 17, 2016

New Study Shows Pulmonary Function Improvement with AffloVest Device

Cystic Fibrosis, News

Austin, Texas-based International Biophysics Corp. (IBC), the developer and manufacturer of the AffloVest airway clearance device for people with pulmonary disorders, recently published a new article titled “Lung function improvement with AffloVest HFCWO ... Read more

May 17, 2016May 17, 2016

Newborn CF Screening Associated with Improved Growth at Puberty and Taller Adults, Study Reports

Cystic Fibrosis, News

Researchers at the University of Wisconsin-Madison reported that newborn screening for cystic fibrosis is associated with improved pubertal development, leading to taller adult height when compared to cystic fibrosis children ... Read more

May 17, 2016May 17, 2016

Galapagos Initiates Phase 1 Study of GLPG2451 for Cystic Fibrosis

Cystic Fibrosis, News

Galapagos NV recently announced the initiation of a phase 1 study investigating its compound GLPG2451 for the treatment of cystic fibrosis (CF). The molecule is the second compound in Galapagos’ extended CF-portfolio to ... Read more

May 16, 2016May 16, 2016

Aradigm’s Candidates for NCFBE Featured at ATS 2016

Bronchiectasis, Cystic Fibrosis, News

The American Thoracic Society (ATS) is hosting the ATS 2016 International Conference through May 18 in San Francisco, Calif. Aradigm, an emerging pharmaceutical focused on drugs for the prevention and ... Read more

May 12, 2016May 12, 2016

CF Foundation Exhibit at Rockerfeller Center shows Challenges, Progress in CF Fight

Cystic Fibrosis, News

The Cystic Fibrosis Foundation is featuring through May, at Rockefeller Center in New York, an impressive window display to raise awareness about cystic fibrosis (CF) – thanks to the space ... Read more

May 11, 2016May 11, 2016

Study Bolsters Support for Newborn Cystic Fibrosis Screenings in Quebec

Cystic Fibrosis, News

A new study led by a team from the Research Institute of the McGill University Health Centre (RI-MUHC) and Cystic Fibrosis Canada strongly supports the benefits of newborn screening programs ... Read more

May 6, 2016May 6, 2016

Concert Pharmaceuticals Announces Promising Phase 1 Trial Data on Modified Version of CF Treatment Ivacaftor

Cystic Fibrosis, News

Promising clinical data from a Phase 1 multiple ascending trial of a deuterium-modified version of the commercially available Kalydeco® (ivacaftor), a drug used to treat cystic fibrosis (CF) in patients ... Read more

May 6, 2016May 6, 2016

CF Foundation Appoints Marc Ginsky as Executive Vice President and Chief Operating Officer

Cystic Fibrosis, News

The Cystic Fibrosis Foundation (CFF), a leading supporter of research into new treatments for cystic fibrosis (CF), recently announced the appointment of Marc Ginsky as its executive vice president and chief ... Read more